Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05013268` - Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma	Phase 1
Completed	`NCT02562729` - Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer	Phase 2
Completed	`NCT00416455` - Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer	Phase 1/Phase 2
Completed	`NCT00054444` - Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer	Phase 1
Recruiting	`NCT05210348` - Clinical Evaluation of Detection of High Risk HPV in Urine
Completed	`NCT01759355` - Hybrid PET/MR in the Therapy of Cervical Cancer
Completed	`NCT00068549` - Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer	Phase 1
Active, not recruiting	`NCT03983954` - Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors	Phase 1
Completed	`NCT00559377` - FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer	Phase 2
Completed	`NCT00309959` - ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer	Phase 2
Active, not recruiting	`NCT05613283` - Primary Cervical Cancer Screening by Self-sampling HPV Test
Completed	`NCT00064077` - Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix	Phase 3
Active, not recruiting	`NCT02466971` - Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers	Phase 3
Completed	`NCT01807546` - Oral Rigosertib for Squamous Cell Carcinoma	Phase 2
Completed	`NCT00031993` - Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix	Phase 2
Active, not recruiting	`NCT01649089` - Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer	N/A
Completed	`NCT00499031` - Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer	Phase 2
Terminated	`NCT00070317` - Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer	N/A
Active, not recruiting	`NCT03738228` - Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer	Phase 1
Completed	`NCT02646319` - Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations	Early Phase 1

NCT number	NCT04976478
Study type	Observational [Patient Registry]
Source	Peking University Third Hospital
Contact	Junjie Wang, MD
Phone	010-82266699
Email	junjiewang_edu@sina.com
Status	Not yet recruiting
Phase
Start date	July 2021
Completion date	December 2026

Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms